Literature DB >> 10580464

COX-1-sparing NSAIDs--is the enthusiasm justified?

W L Peterson, B Cryer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580464     DOI: 10.1001/jama.282.20.1961

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

Review 1.  Conventional treatments for ankylosing spondylitis.

Authors:  M Dougados; B Dijkmans; M Khan; W Maksymowych; Sj van der Linden; J Brandt
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

2.  Prospective study of acute gastrointestinal bleeding attributable to anti-inflammatory drug ingestion in the Yorkshire region of the United Kingdom.

Authors:  C H Lim; R V Heatley
Journal:  Postgrad Med J       Date:  2005-04       Impact factor: 2.401

Review 3.  Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.

Authors:  A J Matheson; D P Figgitt
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease.

Authors:  M Dooley; C M Spencer; C J Dunn
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 5.  Is no NSAID a good NSAID? Approaches to NSAID-associated upper gastrointestinal disease.

Authors:  Stephen Y Chang; Colin W Howden
Journal:  Curr Gastroenterol Rep       Date:  2004-12

6.  Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.

Authors:  C J Hawkey; J Naesdal; I Wilson; G Långström; A J Swannell; R A Peacock; N D Yeomans
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

7.  Outcome trials of COX-2 selective inhibitors: global safety evaluation does not promise benefits.

Authors:  Jorge Gomez Cerezo; Rubin Lubomirov Hristov; Antonio J Carcas Sansuán; Juan J Vázquez Rodríguez
Journal:  Eur J Clin Pharmacol       Date:  2003-04-16       Impact factor: 2.953

Review 8.  Assessing the economic impact of adverse drug effects.

Authors:  Rosa Rodríguez-Monguió; María José Otero; Joan Rovira
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 9.  COX-2 inhibitors in rheumatoid arthritis.

Authors:  J S Sundy
Journal:  Curr Rheumatol Rep       Date:  2001-02       Impact factor: 4.686

10.  Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.

Authors:  Yola Moride; Thierry Ducruet; Jean-François Boivin; Nicholas Moore; Sylvie Perreault; Sean Zhao
Journal:  Arthritis Res Ther       Date:  2005-01-17       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.